NCT00002725View on ClinicalTrials.gov

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

April 30, 2000

Conditions
Lymphoma
Interventions
DRUG

bryostatin 1

DRUG

chemotherapy

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002725 - Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter